Background: Alopecia areata is one of the common causes of nonscarring hair loss with autoimmune etiology. This study was designed to evaluate any added benefit of topical calcipotriol when combined with topical mometasone in the treatment of alopecia areata. To the best of our knowledge, no such study has been conducted in the past. Materials and Methods: It was a comparative analytical study done over 100 patients of clinically diagnosed alopecia areata. Group A patients ( n = 50) were advised to apply topical mometasone 0.1% cream along with topical calcipotriol 0.005% ointment each once daily, whereas patients of Group B ( n = 50) were advised to apply only topical mometasone 0.1% cream in the same amount, once a day. Follow-up of all patients was done at 6, 12, and 24 weeks, and the outcome was assessed according to the Severity of Alopecia Tool (SALT) score at every visit. Results: Both the groups were statistically comparable in terms of age ( P = 0.694) and sex ( P = 0.683) distribution. Baseline mean SALT score of Group A and Group B patients was 7.22 and 6.05, respectively ( P = 0.145). At the end of 24 weeks, mean SALT score of Group A and Group B patients decreased by 4.24 and 3.39, respectively ( P < 0.001). We also found that there was a significant decrease ( P < 0.001) in mean SALT score at 24 weeks in patients of both groups when compared with baseline values. Conclusion: We found that adding topical calcipotriol 0.005% ointment with topical mometasone 0.1% cream has higher efficacy than topical mometasone alone, in the treatment of alopecia areata.
Hutchinson-Gilford progeria syndrome is an extremely rare genetic disorder characterized by premature ageing involving the skin, bones, heart, and blood vessels. The incidence is 1 in several million births. It occurs sporadically and is probably an autosomal dominant syndrome. The diagnosis is essentially clinical and the manifestations become more evident from the first year of life. We report a case of a seven-monthold boy with clinical manifestations characteristic of this syndrome. He had a characteristic "plucked-bird" appearance, prominent eyes and scalp veins, senile look, loss of scalp hair, stunted growth and mottled pigmentation with sclerodermatous changes over the trunk and lower limbs. This interesting case is reported for its rarity. StreSZcZenIe Zespół progerii Hutchinsona-Gilforda to niezwykle rzadki, uwarunkowany genetycznie zespół, który charakteryzuje się przedwczesnym procesem starzenia skóry, kości, serca i naczyń krwionośnych. Częstość występowania wynosi 1 na kilka milionów urodzeń. Zespół występuje sporadycznie i prawdopodobnie jest dziedziczony w sposób autosomalny dominujący. Rozpoznanie opiera się przede wszystkim na ocenie klinicznej, a objawy stają się bardziej widoczne od pierwszego roku życia. Poniższy artykuł przedstawia przypadek siedmiomiesięcznego chłopca z klinicznymi objawami charakterystycznymi dla tego zespołu. Chłopiec miał znamienny wygląd "oskubanego ptaka", tj. nieprawidłowo osadzone oczy, wyraźnie widoczne żyły na skórze głowy, starczy wygląd, nie miał włosów na głowie, przebieg wzrostu był opóźniony, obecne były plamy pigmentacyjne i stwardnienie skóry na tułowiu i kończynach dolnych. Ten interesujący przypadek został opisany ze względu na swoją rzadkość.
Lipoid proteinosis is a rare autosomal recessive genodermatosis characterized by the deposition of hyaline material in the skin and internal organs. Skin involvement is in the form of blisters in infancy healing with pock-like scars, yellow waxy papules, plaques, moniliform blepharosis and diffuse infiltration. Neurological manifestations such as epilepsy, schizophrenia and memory loss have also been reported. We report the case of a 24-year-old female with lipoid proteinosis with neuro-psychiatric symptoms. Her non-contrast computed tomography of the head showed symmetrical calcification involving bilateral medial temporal lobes. We also review the literature on previous publications of lipoid proteinosis cases with neuropsychiatric involvement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.